Interrupt the pain signal. Restore your quality of life.

For appropriate candidates, yes. Peripheral nerve stimulation (PNS) and spinal cord stimulation (SCS) are FDA-cleared and supported by peer-reviewed research and the North American Neuromodulation Society (NANS) consensus guidelines for chronic neuropathic pain. Most importantly, you trial the device before committing — letting you experience the relief firsthand.

Medications often mask pain signals systemically, causing side effects like drowsiness, weight gain, and cognitive fog. Neurostimulation modulates specific pain pathways at the source without systemic medication. For many patients, the effect builds over time as the device is fine-tuned to their specific pattern.

Likely yes. Painful diabetic peripheral neuropathy is one of the most-studied indications for neurostimulation, with research showing meaningful pain reduction and quality-of-life improvement in appropriately selected patients. Our specialists review your underlying condition before recommending an approach.

Yes. Both chemotherapy-induced peripheral neuropathy (CIPN) and small-fiber neuropathy are increasingly treated with neurostimulation. PNS and SCS work the same way regardless of the underlying cause — they modulate the pain signal at the nerve or spinal cord level. Cancer survivors with chronic CIPN often see meaningful relief that medications alone could not provide, and the trial period tells you whether the device will help before any permanent step.

A thin lead is placed near the affected nerve(s) or along the spinal cord under imaging guidance. You wear an external stimulator for 5–7 days and live your normal life, testing whether the stimulation provides meaningful pain relief. If yes, we proceed to permanent implantation. If not, the lead is removed with no permanent change.

The implant sits under the skin like a pacemaker — small, hidden, and rarely noticed in daily life. You control the stimulation via an app or remote and can adjust settings as needed. Modern devices are MRI-conditional under proper protocols.

Rechargeable systems can last 9–15+ years before battery replacement. Non-rechargeable systems typically last 3–5 years depending on usage. Battery replacement is a brief outpatient procedure.

Yes. Both PNS and SCS for chronic neuropathic pain are covered by Medicare and most major insurers when documented criteria are met. We handle prior authorization.

That's exactly what the trial is for — it's a built-in failsafe. If the trial doesn't provide significant relief, you don't proceed to permanent implantation and no permanent change is made.